Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients

This study has been completed.
Information provided by:
Spanish Breast Cancer Research Group Identifier:
First received: August 9, 2005
Last updated: September 4, 2007
Last verified: September 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: December 2006
  Estimated Primary Completion Date: No date given